Praseltinib is specifically made to zero in on and stop the RET kinase, a key player in the growth of lung cancer (NSCLC) and thyroid cancers where RET fuses. It comes as a 100 mg capsule, by the way. The recommended dosage is 400 mg taken once daily, with the requirement for it to be taken on an empty stomach to maximize absorption.
Each bottle holds 60 capsules, like that. The plan is to tackle those gene mutations that are making those cancers grow. It gives therapy that blocks the RET path in a super-targeted way.
Reviews
There are no reviews yet.